Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 38 Neoplasms 33 Depression 28 Fatigue 24 Prostatic Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, Large B-Cell, Diffuse 17 Lymphoma, Follicular 17 Multiple Myeloma 15 Lymphoma, Non-Hodgkin 14 Lymphoma, Mantle-Cell 14 Leukemia, Lymphocytic, Chronic, B-Cell 14 Burkitt Lymphoma 14 Lymphoma, B-Cell, Marginal Zone 13 Leukemia, Myeloid, Acute 13 Hodgkin Disease 13 Colorectal Neoplasms 13 Lymphoma, Large-Cell, Immunoblastic 12 Lung Neoplasms 12 Anxiety Disorders 12 Lymphoma 11 Leukemia, Myeloid, Chronic-Phase 11 Blast Crisis 11 Leukemia, Myeloid, Accelerated Phase 10 Recurrence 9 Pain 9 Lymphoma, T-Cell, Cutaneous 9 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9 Leukemia, Hairy Cell 9 Leukemia 9

Interventions

pembrolizumab 3 atezolizumab 2 Sugammadex 2 Saline Solution 2 Paclitaxel 2 Neostigmine 2 Gemcitabine 2 Cetuximab 2 zidovudine 5'-monophosphate-mannose-albumin conjugate 1 tislelizumab 1 testosterone 17 beta-cypionate 1 temsirolimus 1 relatlimab 1 poly ICLC 1 lenvatinib 1 galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20 1 delta 24-sterol reductase 1 daratumumab 1 cabozantinib 1 abemaciclib 1 Zoledronic Acid 1 Water 1 Valproic Acid 1 Urinary Diversion 1 Ultrasonography 1 Trastuzumab 1 Tomography, Optical Coherence 1 Tissue Banks 1 Therapeutics 1 Testosterone Propionate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Urologic Neoplasms × Therapeutics × Clear all

NCT05038657 2022-10-03

AURORA

University Hospital Southampton NHS Foundation Trust

Phase 2 Unknown

Carcinoma, Squamous Cell, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡